Contribution of infliximab population pharmacokinetic model for dose ptimization in ulcerative colitis patients
Rev. esp. enferm. dig
; 108(2): 104-104, feb. 2016. graf
Article
in English
| IBECS
| ID: ibc-148369
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
No disponible
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Colitis, Ulcerative
/
Antibodies, Monoclonal
Type of study:
Prognostic study
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Rev. esp. enferm. dig
Year:
2016
Document type:
Article
Institution/Affiliation country:
Hospital Universitari Bellvitge/Spain
/
Universitat de Barcelona/Spain